S
SABS//CIK 0001833214
SAB Biotherapeutics, Inc.
Market Data
$3.73−$0.06 (−1.58%)
SABS · Last trade
Prev Close
$3.79
Range (30d)
$3.70 – $4.59
Recent Filings
- 8-K1.1 MBSAB Biotherapeutics, Inc.Mar 18, 8:28 PM ET·0001193125-26-114730
- 8-K15.3 MBSAB Biotherapeutics, Inc.Mar 10, 7:35 AM ET·0001193125-26-099376
- 10-K23.2 MBSAB Biotherapeutics, Inc.Mar 9, 5:10 PM ET·0001833214-26-000003
- 8-K14.1 MBSAB Biotherapeutics, Inc.Jan 12, 4:47 PM ET·0001193125-26-010515
- 8-K268.6 KBSAB Biotherapeutics, Inc.Jan 7, 8:30 AM ET·0001193125-26-005487
- 8-K190.8 KBSAB Biotherapeutics, Inc.Dec 29, 4:00 PM ET·0001193125-25-335267
- 10-Q16.2 MBSAB Biotherapeutics, Inc.Nov 13, 5:43 PM ET·0001193125-25-280572
- 8-K187.9 KBSAB Biotherapeutics, Inc.Sep 30, 4:35 PM ET·0001193125-25-225119
- 8-K495.6 KBSAB Biotherapeutics, Inc.Sep 26, 4:45 PM ET·0001193125-25-220721
- 10-Q13.2 MBSAB Biotherapeutics, Inc.Aug 7, 7:30 AM ET·0000950170-25-104566
Insiders
10- Bausch Christoph LawrenceCHIEF OPERATING OFFICER
- Beyer Russell PChief Financial Officer
- Big Cypress Holdings LLCDirector, CEO and CFO, 10% Owner
- Carillo Carlos NSVP Regulatory Affairs
- Collins Stephen D.Director
- Conley Mark WilliamSee Remarks
- Ellias Helen K.Director
- Erickson Bruce KippChief Operating Officer
- Finnegan FrederickChief Business Officer
- Giberson ScottDirector
Tickers
Addresses
business
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
mailing
777 W 41ST ST SUITE 401
MIAMI BEACH, FL, 33140
Former Names
- Big Cypress Acquisition Corp.2021-10-22